Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29636568 | 1.00 | KMT2A (0.55) | KMT2AMEN1CSNK2A1TSHRCYP2A6 | |
| SCHEMBL471440 | 0.84 | CSNK2A1 (0.69) | KMT2AMEN1CSNK2A1TSHRHSD17B10 | |
| SCHEMBL29495347 | 0.84 | CSNK2A1 (0.69) | KMT2AMEN1CSNK2A1TSHRHSD17B10 | |
| SCHEMBL12986352 | 0.83 | CSNK2A1 (0.50) | KMT2AMEN1CSNK2A1CYP2A6SMN1; SMN2 | |
| SCHEMBL9862051 | 0.83 | MEN1 (0.57) | KMT2AMEN1CSNK2A1TSHRSMN1; SMN2 | |
| SCHEMBL9420245 | 0.83 | MEN1 (0.57) | KMT2AMEN1CSNK2A1TSHRSMN1; SMN2 | |
| SCHEMBL9969949 | 0.82 | MEN1 (0.52) | KMT2AMEN1CSNK2A1TSHRSMN1; SMN2 | |
| SCHEMBL223101 | 0.81 | CSNK2A1 (0.65) | KMT2AMEN1CSNK2A1TSHRSMN1; SMN2 | |
| SCHEMBL96218 | 0.81 | KMT2A (0.51) | KMT2AMEN1CSNK2A1CYP2A6SMN1; SMN2 | |
| SCHEMBL29381894 | 0.81 | KMT2A (0.51) | KMT2AMEN1CSNK2A1CYP2A6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118325204-A | Low-temperature-rise rubber and carbon black composition and preparation method thereof | 华南理工大学 | 2024-07-12 | — | — | CN | claimed |
| US-9714560-B2 | Protected scale inhibitors and methods relating thereto | HALLIBURTON ENERGY SERVICES, INC. (US) | 2017-07-25 | — | — | US | claimed |
| US-6444195-B1 | MIXTURE OF DIBENZOYLMETHANE AND BENZOPHENONE COMPOUND | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2002-09-03 | — | — | US | claimed |
| WO-2002017873-A1 | SUNSCREEN COMPOSITIONS CONTAINING A DIBENZOYLMETHANE DERIVATIVE AND A TRIAZINE DERIVATIVE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-03-07 | — | — | WO | claimed |
| WO-2002017872-A1 | SUNSCREEN COMPOSITIONS CONTAINING TITANIUM DIOXIDE AND TRIAZINE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-03-07 | — | — | WO | claimed |
| CN-118325204-A | Low-temperature-rise rubber and carbon black composition and preparation method thereof | 华南理工大学 | 2024-07-12 | — | — | CN | disclosed |
| US-20240208912-A1 | MTA-Cooperative PRMT5 Inhibitors | MIRATI THERAPEUTICS INC (US) | 2024-06-27 | — | — | US | disclosed |
| CN-117986153-A | Ionizable cationic lipid compound, and preparation method and application thereof | 晟迪生物医药(苏州)有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117568821-A | Electrochemical synthesis method of quinoxaline derivative | 齐齐哈尔医学院 | 2024-02-20 | — | — | CN | disclosed |
| WO-2023224998-A1 | INHIBITORS OF PARG | 858 THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| US-20230130025-A1 | PHOTORESIST COMPOSITIONS AND METHODS FOR FABRICATING SEMICONDUCTOR DEVICE USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230130025-A1 | PHOTORESIST COMPOSITIONS AND METHODS FOR FABRICATING SEMICONDUCTOR DEVICE USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| US-4665181-A | Anti-inflammatory phthalazinones | PENNWALT CORPORATION (US) | 1987-05-12 | — | — | US | disclosed |
| US-4562067-A | Preparation of novel dibenzoylmethane derivative sunscreen agents | HAARMANN & REIMER GMBH (DE) | 1985-12-31 | — | — | US | disclosed |
| EP-0164593-A1 | Anti-inflammatory phthalazinones | FISONS CORPORATION (US) | 1985-12-18 | — | — | EP | disclosed |
| EP-0114607-B1 | DIBENZOYL METHANE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE | HAARMANN & REIMER GMBH (DE) | 1985-09-04 | — | — | EP | disclosed |
| US-4489057-A | DIBENZOYLMETHANE COMPOUNDS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1984-12-18 | — | — | US | disclosed |
| EP-0114607-A1 | Dibenzoyl methane derivatives, process for their production and their use | HAARMANN & REIMER GMBH (DE) | 1984-08-01 | — | — | EP | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-3931152-A | ANTITUBERCULAR | AMERICAN CYANAMID COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208912-A1 | MTA-Cooperative PRMT5 Inhibitors | PRMT1, PRMT5, PRMT6 | KMT2A 165/4885MEN1 677/4885CSNK2A1 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.